Fresh on the heels of another investment from Canopy Rivers, Canapar breaks ground on a Sicilian hemp processing facility said to be “Europe’s largest.”
What does this mean for the bid and the price of cannabis in Europe?
Avoid these common mistakes when labeling your products- some of them could raise your production costs considerably.
The World Health Organization is making conservative, forward-looking statements about reconsidering the medical efficacy of cannabis, but what does it really mean?
Canadian companies like Canopy, Aurora and TGOD continue to establish footprints across Europe.
Their facility in Gainesville, Florida received the GMP certification, indicating that it now meets Florida’s regulatory requirements for producing medical cannabis products.
Avoid these common mistakes when labeling your products- some of them could raise your production costs considerably.
Israel’s cabinet finally approved the much heralded, long pushed and politically delayed cannabis export law.
An innovative Swiss start-up began working with a U.S.-based partner to bring hemp-based wellness products and even pharmaceuticals to EU markets
In this Op-Ed, Dr. Markus Roggen discusses the evolution of cannabis science and why we need more experiment-based research.
